SEARCH Articles Figures Tables Alteplase in venous thromboembolism Anticoagulants in venous thromboembolism Anticoagulation thromboembolic complications Arterial thromboembolic events Arterial thromboembolism Aspirin prevents platelet aggregation and may be helpful in the treatment of thromboembolic disease Atrial arrhythmias thromboembolism risk Cancer venous thromboembolism Cardiovascular venous thromboembolism, oral Chronic thromboembolic pulmonary Chronic thromboembolic pulmonary hypertension Coagulation venous thromboembolism Coumarin anticoagulants thromboembolism Dalteparin in venous thromboembolism Deep vein thromboembolism Deep vein thromboembolism incidence Enoxaparin in venous thromboembolism Estrogen therapy venous thromboembolism with Estrogen thromboembolism from Fibrillation thromboembolism risk Fondaparinux in venous thromboembolism Heparin in venous thromboembolism Heparins thromboembolic events Hormonal contraceptives thromboembolism Hormone replacement therapy thromboembolism INDEX thromboembolism Massive pulmonary thromboembolism Olanzapine thromboembolism Oral contraceptives venous thromboembolism Oral contraceptives venous thromboembolism with Patient safety thromboembolism Prolyse in acute cerebral thromboembolism Pulmonary embolism thromboembolism Pulmonary thromboembolism Pulmonary thromboembolism clozapine Streptokinase in venous thromboembolism Tamoxifen thromboembolism Thromboembolic complications Thromboembolic complications, nephrotic Thromboembolic complications, nephrotic syndrome Thromboembolic diseases Thromboembolic disorders Thromboembolic disorders pregnancy Thromboembolic disorders venous Thromboembolic disorders, treatment Thromboembolic event Thromboembolic events bevacizumab Thromboembolic phenomena Thromboembolic potential Thromboembolic stroke Thromboembolism clinical presentation Thromboembolism definition Thromboembolism diagnosis Thromboembolism direct thrombin inhibitors Thromboembolism fondaparinux Thromboembolism frequency Thromboembolism heparin therapy Thromboembolism incidence Thromboembolism oral contraceptives Thromboembolism pathophysiology Thromboembolism prevention Thromboembolism streptokinase Thromboembolism thrombolytic agents Thromboembolism venous Thromboembolism warfarin therapy Thromboembolism with oral contraceptives Thrombolytic therapy in venous thromboembolism Venous thromboembolic disease Venous thromboembolic events Venous thromboembolism anticoagulants Venous thromboembolism approach Venous thromboembolism case study Venous thromboembolism clinical presentation Venous thromboembolism clozapine Venous thromboembolism concentrate Venous thromboembolism diagnosis Venous thromboembolism direct thrombin inhibitors Venous thromboembolism emerging treatments Venous thromboembolism epidemiology Venous thromboembolism fondaparinux Venous thromboembolism heparins Venous thromboembolism pathophysiology Venous thromboembolism prevention Venous thromboembolism recurrent Venous thromboembolism thrombolytic therapy Venous thromboembolism thrombolytics Venous thromboembolism thrombosis Pulmonary embolism Venous thromboembolism treatment Venous thromboembolism unfractionated heparin Venous thromboembolism vein thrombosis Pulmonary embolism Venous thromboembolism warfarin Venous thromboembolism with heparin-induced thrombocytopenia Venous thromboembolism with raloxifene Venous thromboembolism with/without Venous thromboembolism with/without treatments Venous thromboembolism, oral Venous thromboembolism, oral contraceptive risk Warfarin in venous thromboembolism